Sites et mécanismes d'action de la mélatonine chez les Mammifères : les récepteurs MT1 et MT2

By Schuster Carole  

Journal de la Société de Biologie, Vol. 201, Iss. 1, 2010-03 ,pp. : 85-96

Edp Sciences

Access to resources Recommend Favorite

A Novel and Selective Nociceptin Receptor (NOP) Agonist (1‐(1‐((cis)‐4‐isopropylcyclohexyl)piperidin‐4‐yl)‐1H‐indol‐2‐yl)methanol (AT‐312) Decreases Acquisition of Ethanol‐Induced Conditioned Place Preference in Mice

By  

ALCOHOLISM (ELECTRONIC), Vol. 42, Iss. 2, 2018-02 ,pp. : 461-471

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical features of unilateral headaches beyond migraine and cluster headache and their response to indomethacin

By Seidel Stefan  

Wiener klinische Wochenschrift, Vol. 123, Iss. 17-18, 2011-09 ,pp. : 536-541

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 525-533

John Wiley & Sons Inc

Access to resources Recommend Favorite

MT1-MMP-Mediated Cleavage of Decorin in Corneal Angiogenesis

By  

Journal of Vascular Research, Vol. 46, Iss. 6, 2009-06 ,pp. : 541-550

Karger

Access to resources Recommend Favorite